Advances in the treatment of Hodgkin's lymphoma (Review).

Che, Yuxuan; Ding, Xiaolei; Xu, Liye; Zhao, Jian; Zhang, Xian; Li, Na; Sun, Xiuhua

Che, Yuxuan; Ding, Xiaolei; Xu, Liye; Zhao, Jian; Zhang, Xian; Li, Na; Sun, Xiuhua.

Afiliação

Che Y; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Ding X; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Xu L; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Zhao J; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Zhang X; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Li N; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Sun X; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.

Int J Oncol ; 62(5)2023 May.

Article em En | MEDLINE | ID: mdl-37026506

Assuntos

Doença de Hodgkin; Imunoconjugados; Humanos; Doença de Hodgkin/induzido quimicamente; Doença de Hodgkin/tratamento farmacológico; Brentuximab Vedotin/uso terapêutico; Imunoconjugados/efeitos adversos; Resultado do Tratamento; Recidiva Local de Neoplasia/tratamento farmacológico; Microambiente Tumoral

Palavras-chave

Hodgkin's lymphoma; brentuximab vedotin; cell therapy; immunotherapy; novel therapies; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google